[go: up one dir, main page]

Ma et al., 2019 - Google Patents

Construction of a New Style Injectable Tissue Engineering Nucleus Pulposus In Vitro

Ma et al., 2019

Document ID
7573171041435405586
Author
Ma J
Fu X
Jing J
Li F
Ren D
Publication year
Publication venue
Journal of Biomaterials and Tissue Engineering

External Links

Snippet

The goal of the study is to explore the feasibility of platelet-rich plasma gel as scaffold and adipose derived stromal cells as seed cells construction of injectable tissue engineering nucleus pulposus in vitro. After the rabbit adipose derived stromal cells (ADSCs) were …
Continue reading at www.ingentaconnect.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/105—Insulin-like growth factors [IGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/42—Organic phosphate, e.g. beta glycerophosphate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology

Similar Documents

Publication Publication Date Title
Twomey-Kozak et al. Meniscus repair and regeneration: a systematic review from a basic and translational science perspective
CA2629405C (en) Tissue engineering methods and compositions
Nesti et al. Differentiation potential of multipotent progenitor cells derived from war-traumatized muscle tissue
Berg et al. Chondrogenic potential of mesenchymal stromal cells derived from equine bone marrow and umbilical cord blood
Park et al. Transgene‐activated mesenchymal cells for articular cartilage repair: a comparison of primary bone marrow‐, perichondrium/periosteum‐and fat‐derived cells
Mendelson et al. Chondrogenesis by chemotactic homing of synovium, bone marrow, and adipose stem cells in vitro
Park et al. Chondrogenic potential of stem cells derived from amniotic fluid, adipose tissue, or bone marrow encapsulated in fibrin gels containing TGF-β3
Rizk et al. Human dental pulp stem cells expressing transforming growth factor β3 transgene for cartilage-like tissue engineering
Sheykhhasan et al. Fibrin scaffolds designing in order to human adipose-derived mesenchymal stem cells differentiation to chondrocytes in the presence of TGF-β3
Krüger et al. Human platelet‐rich plasma induces chondrogenic differentiation of subchondral progenitor cells in polyglycolic acid–hyaluronan scaffolds
Zhang et al. Differentiation of adipose-derived stem cells toward nucleus pulposus-like cells induced by hypoxia and a three-dimensional chitosan-alginate gel scaffoldin vitro
Breathwaite et al. Scaffold-free bioprinted osteogenic and chondrogenic systems to model osteochondral physiology
Lee et al. Characterization and spinal fusion effect of rabbit mesenchymal stem cells
Remya et al. Mechanoresponsiveness of human umbilical cord mesenchymal stem cells in in vitro chondrogenesis—a comparative study with growth factor induction
Zhang et al. A possible injectable tissue engineered nucleus pulposus constructed with platelet-rich plasma and ADSCs in vitro
AU2013222002B2 (en) Tissue engineering methods and compositions
Ma et al. Construction of a New Style Injectable Tissue Engineering Nucleus Pulposus In Vitro
Fan et al. Enhancing synovial mesenchymal stem cell adhesion and selection via an avidin-biotin-CD105 binding system for cartilage tissue engineering
Xu et al. Co-culture of annulus fibrosus cells and bone marrow mesenchymal stem cells
Branquinho et al. Synovia-derived mesenchymal stem cell application in musculoskeletal injuries: a review
Music Optimisation of methods for driving Chondrogenesis of human and ovine bone marrow–derived stromal cells
Schwarz The potential of Integrin α10β1-selected mesenchymal stem cells for therapy of post-traumatic osteoarthritis in a mouse model
JP2023159260A (en) efficacy test
Viswanathan et al. Regenerative Medicine Approaches for Treatment of Osteoarthritis
ES2372239B2 (en) METHOD FOR PRODUCING MESENQUIMAL TRONCAL CELLS DERIVED FROM ADIPOSE TISSUE, AS WELL AS THE MESENQUIMAL TRONCELL CELLS OBTAINED BY SUCH METHOD.